Comment on: Trends in blood transfusion, hydroxyurea use, and iron overload among children with sickle cell disease enrolled in Medicaid, 2004-2019. Emerging therapeutic options for sickle cell anemia: Enhancing the current predominant treatment

Pediatr Blood Cancer. 2023 May 30:e30439. doi: 10.1002/pbc.30439. Online ahead of print.
No abstract available

Publication types

  • Letter